Skip to main content
Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. logo

Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. — Investor Relations & Filings

Ticker · 301584 ISIN · CNE100007978 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 126 across all filing types
Latest filing 2026-05-25 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 301584

About Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd.

https://www.innostic.com

Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. specializes in providing integrated supply chain services and technical solutions for the in-vitro diagnostics (IVD) sector. The company operates as a comprehensive service provider, focusing on the distribution of medical devices, intensive procurement management for healthcare institutions, and specialized logistics. Its core offerings include the management of diagnostic reagents and consumables, equipment maintenance, and the implementation of digital laboratory information systems. By leveraging advanced supply chain management technologies, the group optimizes procurement processes and inventory control for hospitals and clinical laboratories. The company integrates professional technical support with efficient distribution networks to ensure the reliable delivery and operation of diagnostic technologies across its target markets.

Recent filings

Filing Released Lang Actions
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 98% confidence The document is an official announcement by Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. detailing the 2025 annual equity distribution plan, including the per-share cash dividend amount, record date, ex-dividend date, payment methods, tax details, and related procedures. It precisely matches the definition of a Notice of Dividend Amount (DIV).
2026-05-25 Chinese
关于签署募集资金监管协议的公告
Capital/Financing Update Classification · 82% confidence The document is a formal announcement by Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. regarding the signing of a fundraising supervision agreement (‘募集资金监管协议’) following its IPO. It details the amount raised, account setup, and regulatory oversight mechanisms for the proceeds. This is clearly an update on the company’s fundraising activities and capital management rather than a full financial report, dividend notice, or corporate governance change. Therefore, it best fits the Capital/Financing Update category (CAP).
2026-05-22 Chinese
上海建发致新医疗科技集团股份有限公司投资者关系活动记录表
Call Transcript Classification · 75% confidence The document is an investor relations record of a “业绩说明会” (earnings explanation meeting) including Q&A dialogue between investors and the company’s management. This aligns with a conference call or meeting transcript of an earnings event rather than a formal financial report or simple announcement. Therefore, the most appropriate category is a Call Transcript.
2026-05-12 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the 2025 annual general shareholders’ meeting resolutions, detailing attendance figures and voting outcomes for each proposal. This aligns precisely with the definition of a Declaration of Voting Results & Voting Rights Announcements, which reports official shareholder vote results at a general meeting.
2026-05-11 Chinese
北京国枫律师事务所关于上海建发致新医疗科技集团股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a legal opinion letter from the company’s external counsel regarding the 2025 Annual General Meeting. It provides detailed voting results for each proposal (votes for, against, abstentions, percentages). This aligns precisely with the “Declaration of Voting Results & Voting Rights Announcements” category, which covers official results from shareholder votes at general meetings (AGM/EGM).
2026-05-11 Chinese
关于举行2025年度暨2026年第一季度网上业绩说明会的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about holding an online earnings explanation meeting (业绩说明会) for the 2025 fiscal year and the first quarter of 2026. It includes details about the meeting date, participants, and how investors can join and submit questions. The document does not contain actual financial statements or detailed financial analysis but rather invites investors to attend a presentation and Q&A session. This matches the definition of a Call Transcript (CT) or Investor Presentation (IP) only if the transcript or presentation is included. However, since this is only an announcement of the upcoming earnings call/meeting and not the transcript or presentation itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the event. The document length is short (672 characters), and it does not contain financial data or the actual report, so it is not an Interim Report (IR) or Earnings Release (ER).
2026-05-07 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.